Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.9%

87 terminated/withdrawn out of 877 trials

Success Rate

86.1%

-0.4% vs industry average

Late-Stage Pipeline

9%

82 trials in Phase 3/4

Results Transparency

38%

202 of 537 completed trials have results

Key Signals

135 recruiting202 with results54 terminated33 withdrawn

Enrollment Performance

Analytics

N/A
347(54.6%)
Phase 2
96(15.1%)
Phase 1
93(14.6%)
Phase 4
48(7.5%)
Phase 3
34(5.3%)
Early Phase 1
18(2.8%)
636Total
N/A(347)
Phase 2(96)
Phase 1(93)
Phase 4(48)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (877)

Showing 20 of 877 trials
NCT05660746Phase 2Recruiting

Precise Infliximab Exposure and Pharmacodynamic Control

Role: lead

NCT04621279Recruiting

Cool Prime Comparative Effectiveness Study for Mild HIE

Role: collaborator

NCT06305078Not ApplicableCompleted

Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Experiment Study

Role: lead

NCT07560007Active Not Recruiting

The Bleeding Assessment Tool (BAT)

Role: lead

NCT07422012Not Yet Recruiting

Tacrolimus in Pregnancy

Role: collaborator

NCT01120353Recruiting

Childhood Cancer Survivor Study

Role: collaborator

NCT07549646Phase 2Active Not Recruiting

24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs

Role: collaborator

NCT05579639Phase 2Recruiting

Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant

Role: lead

NCT02947633Not ApplicableCompleted

Sciatic Technique Comparison of Nerve Blockade for Pain Control Following Hamstring Autograft Harvest in Adolescents

Role: lead

NCT07543822Phase 2Active Not Recruiting

24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs

Role: collaborator

NCT04481035Phase 2Completed

Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1

Role: lead

NCT02793375Phase 3Completed

Does Montelukast Decrease Post Adenotonsillectomy Pain in Children

Role: lead

NCT06171217Phase 2Active Not Recruiting

Realizing Effectiveness Across Continents With Hydroxyurea

Role: lead

NCT01129544Phase 1Completed

Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

Role: collaborator

NCT04113434Completed

Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome

Role: collaborator

NCT03476330Phase 2Completed

Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia

Role: lead

NCT04670016Completed

HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers

Role: collaborator

NCT06615375Phase 2Active Not Recruiting

A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine

Role: collaborator

NCT03260387Active Not Recruiting

A Prospective Observational Study of TPIAT

Role: collaborator

NCT03707431Not ApplicableCompleted

Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis

Role: collaborator